DC Investments Management’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-2,992
Closed -$438K 312
2018
Q1
$438K Buy
+2,992
New +$506K 0.29% 116

Other funds holding CDLX

DC Investments Management's CDLX Position: Q2 2018 in Review

DC Investments Management sold out of Cardlytics (CDLX) in Q2 2018, closing a stake of 2,992 shares — an estimated $438K sold.

DC Investments Management first reported a position in CDLX in Q1 2018 and held it in 1 quarter. The position peaked at $438K in Q1 2018. 53 funds tracked by Wall St. Rank hold CDLX as of Q2 2018.

  • DC Investments Management reported no remaining Cardlytics position as of Q2 2018 after selling out during the quarter.
  • DC Investments Management sold 2,992 Cardlytics shares in Q2 2018, an estimated $438K.
  • DC Investments Management first reported a position in Cardlytics in Q1 2018 and held it in 1 quarter.
  • DC Investments Management's Cardlytics position peaked at $438K in Q1 2018.
  • 53 funds tracked by Wall St. Rank held Cardlytics as of Q2 2018.

Based on DC Investments Management's 13F filing for Q2 2018, filed 3 Aug 2018.